Circ_0025373 inhibits carbon black nanoparticles-induced malignant transformation of human bronchial epithelial cells by affecting DNA damage through binding to MSH2

• Published in: Environment international 2024-09, Vol.191, p.109001, Article 109001
• Main Authors: Zhang, Han, Lu, Wenfeng, Qiu, Lan, Li, Saifeng, Qiu, Liqiu, He, Mengnan, Chen, Xintong, Wang, Jiajing, Fang, Jingwen, Zhong, Chenghui, Lan, Meiqi, Xu, Xiaole, Zhou, Yun
• Format: Article
• Language: English
• Subjects: Bronchi - pathology; Carbon black nanoparticles; Cell Line; Cell Transformation, Neoplastic; CircRNA; DNA Damage; DNA repair; Epithelial Cells - drug effects; Epithelial Cells - metabolism; Humans; Malignant transformation; MutS Homolog 2 Protein - genetics; MutS Homolog 2 Protein - metabolism; Nanoparticles - chemistry; RNA, Circular - genetics; RNA, Circular - metabolism; Soot - toxicity
• ISSN: 0160-4120; 1873-6750; 1873-6750
• DOI: 10.1016/j.envint.2024.109001

[Display omitted] Carbon black nanoparticles (CBNPs) have been demonstrated to induce DNA damage in epithelial cells. However, the potential of the damage to initiate carcinogenesis and the underlying mechanism remain poorly understood. Therefore, we constructed an in vitro model of malignant transformation of human bronchial epithelial cells (16HBE-T) by treating 40 μg/mL CBNPs for 120 passages. We observed tumor-like transformation and sustained DNA damage. Using transcriptome sequencing and RIP-seq, we identified the overexpression of the critical DNA mismatch repair genes MutS homolog 2 (MSH2) and its related circular RNA, circ_0025373, in the 16HBE-T cells. Mechanistically, circ_0025373 was found to inhibit DNA damage by binding to MSH2, thereby modifying its expression and influencing its nuclear and cytoplasmic distribution, which lead to inhibition of CBNP-induced malignant transformation of human bronchial epithelial cells. Our findings provide novel evidence on the carcinogenicity of CBNPs, and offer biological insights into the potential epigenetic regulation and potential therapeutic targets for lung carcinogenesis.